Joost von Schmidt, MD, of Leiden University Medical Center, discusses his research into the association between preeclampsia and postpartum hemorrhage during the poster session at the Society of Maternal and Fetal Medicine's 32nd Annual Meeting.
Joost von Schmidt, MD, of Leiden University Medical Center, discusses his research into the association between preeclampsia and postpartum hemorrhage during the poster session at the Society of Maternal and Fetal Medicine's 32nd Annual Meeting. A transcript of the video is below.
I’m Joost von Schmidt, I’m from Leiden University Medical Center, and I’m here to present my research which was about preeclampsia and the association between preeclampsia and postpartum hemorrhage.
We looked at the association between preeclampsia and postpartum hemorrhage in a large database, more than 340,000 deliveries in the Netherlands, both hospital and home births-so both high- and low-risk pregnancies-and they have a great coverage of 95% of midwife practices and 99% of hospital registries.
We defined preeclampsia as a minimum of 90 diastolic blood pressure and the occurrence of proteinuria, and also, of course, we defined postpartum hemorrhage as 1,000 milliliters of blood loss.
Afterwards we identified confounders for the association of preeclampsia and postpartum hemorrhage, which were maternal age, parity, socioeconomic status, multiple pregnancies, and gestational age.
Through multivariate analysis we corrected for the confounders and after correction we still saw an increased risk of 1.5 odds ratio. So… there is increased risk, a 1.5-fold increased risk, of postpartum hemorrhage when someone has preeclampsia. Clinicians should be aware of that when they manage the third stage of labor.
The only thing that we weren’t able to correct for is magnesium sulfate use, so that’s one of the things we have to look at in the future research. Thank you.
Read our complete coverage of the Society of Maternal and Fetal Medicine's 32nd Annual Meeting, including:
SMFM: Progesterone Does Not Prolong Pregnancy After Successful Tocolytic Treatment
SMFM: Induction of Labor Reduces Trauma Risk for Large-for-Date Fetuses
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More